Clinical Thyroidology for the Public
VOLUME 13 ISSUE 7 July 2020

In this issue, the studies ask the following questions:

• What is the best treatment for Graves' disease?
• Does changing brands of levothyroxine alter thyroid function tests?
• Does the heart beat stronger with thyroid hormone treatment in older patients with mild hypothyroidism?
• Does amiodarone therapy increase the risk of developing thyroid storm?
• What are patient preferences for surgery in low risk thyroid cancer?
  
• Does extension of thyroid cancer outside of the thyroid impact response to therapy?
  

We welcome your feedback and suggestions. Let us know what you want to see in this publication.

ATA Thyroid Twitter Chats #thyroidchat – Coming Soon!

The ATA is embarking upon a new public and patient initiative to provide reliable thyroid information to patients and their families.  The ATA will be hosting and participating in several Twitter Chats through the end of the year. The first ATA hosted chat is planned for August during Thyroid and Pregnancy Awareness Month – the exact date and topics will be available soon. We look forward to this initiative for delivering dependable thyroid education and awareness to the community, please keep an eye on your ATA social media channels for updates coming soon! #AmericanThyroidAssociation #ATAThyroid2020

Thyroid Research Awards 2020

Dr. Jennifer Kuo was awarded a ThyCa research grant to evaluate the safety & efficacy of ultrasound guided radiofrequency ablation for treatment of benign & malignant thyroid nodules in the U.S.

View this video to hear more about Dr. Kuo's research.

Novel Coronavirus (COVID-19) and the Thyroid: Frequently Asked Questions

Q: Are people with autoimmune thyroid disease, such as Hashimoto's thyroiditis or Graves' disease, at more risk for acquiring COVID-19 or having a more serious COVID-19 infection?

A: The U.S. Centers for Disease Control (CDC) advises that people who are immunocompromised are at higher-risk of severe illness from COVID-19. Immunocompromised people have a weaker immune system and have a harder time fighting infections. However, the immune system is complex, and having autoimmune thyroid disease does not mean that a person is immunocompromised or will be unable to fight off a viral infection. Thus far, there is no indication that patients with autoimmune thyroid disease are at greater risk of getting COVID-19 or of being more severely affected should they acquire the COVID-19 infection. Everyone should continue to practice the recommended hand hygiene and social distancing recommendations to avoid COVID-19 infection. Read More....

July is Graves' Disease Awareness Month

The American Thyroid Association is dedicated to the advancement, understanding, prevention, diagnosis and treatment of thyroid disorders and thyroid cancer. With your support the ATA will continue to develop key resources on thyroid cancer, thyroid disease and build information on pediatric thyroid conditions. Your donations will also help expand our brochures into different languages.

• Graves' Disease Brochure
• El folleto de Enfermedad De Graves